Fidelity Investments
OLMA icon

Fidelity Investments’s Olema Pharmaceuticals OLMA Stock Holding History

Fidelity Investments’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$155M Buy
10,386,845
+5,363,753
+107% +$119M 0.01% 977
2025
Q4 		$126M Buy
5,023,092
+4,993,670
+16,973% +$88.9M 0.01% 1072
2025
Q3 		$288K Buy
29,422
+1,181
+4% +$7.09K ﹤0.01% 3228
2025
Q2 		$120K Buy
28,241
+26,426
+1,456% +$118K ﹤0.01% 3529
2025
Q1 		$6.82K Sell
1,815
-44,013
-96% -$221K ﹤0.01% 4609
2024
Q4 		$267K Buy
45,828
+43,927
+2,311% +$439K ﹤0.01% 3160
2024
Q3 		$22.7K Buy
1,901
+865
+83% +$11.1K ﹤0.01% 4122
2024
Q2 		$11.2K Buy
1,036
+40
+4% +$434 ﹤0.01% 4295
2024
Q1 		$11.3K Buy
996
+88
+10% +$1.14K ﹤0.01% 4231
2023
Q4 		$12.7K Sell
908
-728
-44% -$9.78K ﹤0.01% 4160
2023
Q3 		$20.2K Buy
1,636
+972
+146% +$9.91K ﹤0.01% 3796
2023
Q2 		$6K Sell
664
-8
-1% -$48 ﹤0.01% 4309
2023
Q1 		$2.33K Sell
672
-24
-3% -$98 ﹤0.01% 4591
2022
Q4 		$1.71K Buy
696
+342
+97% +$997 ﹤0.01% 4551
2022
Q3 		$1K Sell
354
-3,579
-91% -$15.2K ﹤0.01% 4717
2022
Q2 		$16K Sell
3,933
-104,712
-96% -$332K ﹤0.01% 3962
2022
Q1 		$463K Sell
108,645
-454,209
-81% -$2.5M ﹤0.01% 3010
2021
Q4 		$5.27M Sell
562,854
-44,197
-7% -$916K ﹤0.01% 2351
2021
Q3 		$16.7M Sell
607,051
-35,700
-6% -$964K ﹤0.01% 1924
2021
Q2 		$18M Sell
642,751
-9,946
-2% -$283K ﹤0.01% 1886
2021
Q1 		$21.7M Sell
652,697
-1,800
-0.3% -$77.1K ﹤0.01% 1772
2020
Q4 		$31.5M Buy
+654,497
New +$30.7M ﹤0.01% 1509

Other funds holding OLMA

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments's OLMA Position: Q1 2026 in Review

Fidelity Investments increased its Olema Pharmaceuticals (OLMA) stake by 107% in Q1 2026, buying an estimated $119M and bringing the position to 10,386,845 shares worth $155M. The position accounts for 0.01% of the portfolio, ranked #977.

Fidelity Investments first reported a position in OLMA in Q4 2020 and has held it in 22 quarters since. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Fidelity Investments held 10,386,845 shares of Olema Pharmaceuticals worth $155M as of Q1 2026.
  • Fidelity Investments bought 5,363,753 Olema Pharmaceuticals shares in Q1 2026, an estimated $119M.
  • Olema Pharmaceuticals made up 0.01% of Fidelity Investments's portfolio in Q1 2026, its #977 holding.
  • Fidelity Investments first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.